{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:15:00Z","timestamp":1790806500624,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shanghai Municipal Science & Technology Program","award":["16411968700"],"award-info":[{"award-number":["16411968700"]}]},{"name":"Shanghai Municipal Science & Technology Program","award":["16410722800"],"award-info":[{"award-number":["16410722800"]}]},{"name":"Shanghai Municipal Science & Technology Program","award":["17511107103"],"award-info":[{"award-number":["17511107103"]}]}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejrad.2018.04.020","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T17:59:40Z","timestamp":1524419980000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["18 F-FDG PET\/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI"],"prefix":"10.1016","volume":"104","author":[{"given":"Weiyan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixingzi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoying","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2018.04.020_bib0005","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.10851","article-title":"The continuing increase in the incidence of primary central nervous system non-hodgkin lymphoma: a surveillance, epidemiology, and end results analysis","volume":"95","author":"Olson","year":"2002","journal-title":"Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ejrad.2018.04.020_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10428190802311441","article-title":"Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment","volume":"49","author":"Rubenstein","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3174\/ajnr.A3383","article-title":"Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction","volume":"34","author":"Toh","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0020","doi-asserted-by":"crossref","first-page":"247152","DOI":"10.1155\/2013\/247152","article-title":"18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma","volume":"2013","author":"Kawai","year":"2013","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1215\/15228517-2007-061","article-title":"The utility of body FDG PET in staging primary central nervous system lymphoma","volume":"10","author":"Mohile","year":"2008","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.rlu.0000257269.99345.1b","article-title":"Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma","volume":"32","author":"Karantanis","year":"2007","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0035","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00259-013-2448-1","article-title":"18F-FDG PET\/CT in HIV-related central nervous system pathology","volume":"40","author":"Lewitschnig","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0040","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.07.2660","article-title":"18F-FDG PET of common enhancing malignant brain tumors","volume":"190","author":"Kosaka","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12149-014-0851-8","article-title":"The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma","volume":"28","author":"Yamaguchi","year":"2014","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/RLU.0b013e318279b6cc","article-title":"The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients","volume":"38","author":"Shi","year":"2013","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1025665820001","article-title":"Prediction of pathology and survival by FDG PET in gliomas","volume":"64","author":"Padma","year":"2003","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0060","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF02985117","article-title":"Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis","volume":"19","author":"Kawai","year":"2005","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0065","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.crad.2016.05.017","article-title":"Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment","volume":"71","author":"Zhang","year":"2016","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0070","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3174\/ajnr.A4867","article-title":"Diffusion-weighted imaging for predicting and monitoring primary central nervous system lymphoma treatment response","volume":"37","author":"Huang","year":"2016","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11060-010-0182-0","article-title":"Prognostic value of pretreatment 18F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment","volume":"100","author":"Kawai","year":"2010","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2967\/jnumed.112.108654","article-title":"18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma","volume":"54","author":"Kasenda","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0085","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuroimage.2016.09.031","article-title":"Data-driven identification of intensity normalization region based on longitudinal coherency of 18F-FDG metabolism in the healthy brain","volume":"146","author":"Zhang","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/RLU.0000000000000649","article-title":"13N-ammonia combined with 18F-FDG could discriminate between necrotic high-grade gliomas and brain abscess","volume":"40","author":"Shi","year":"2015","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00234-012-1089-6","article-title":"Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and 18F-fluorodeoxyglucose positron emission tomography","volume":"55","author":"Yamashita","year":"2013","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12149-011-0483-1","article-title":"Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study","volume":"25","author":"Makino","year":"2011","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0720-048X(99)00099-6","article-title":"Cerebral perfusion SPECT in transient ischemic attack","volume":"34","author":"You","year":"2000","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ejrad.2016.02.015","article-title":"Correlation of the suvmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma","volume":"85","author":"Kitajima","year":"2016","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/RLU.0b013e318248524a","article-title":"FDG PET\/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient","volume":"37","author":"Nakajo","year":"2012","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12149-012-0570-y","article-title":"Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma","volume":"26","author":"Matsushima","year":"2012","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0125","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.ejrad.2011.04.062","article-title":"No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET\/CT and DW-MRI study","volume":"79","author":"Wu","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00259-010-1718-4","article-title":"Functional imaging in head and neck squamous cell carcinoma: correlation of PET\/CT and diffusion-weighted imaging at 3 Tesla","volume":"38","author":"Fruehwald-Pallamar","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0135","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00259-013-2351-9","article-title":"Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET\/CT: quantitative analysis of ADC and SUV","volume":"40","author":"Varoquaux","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","article-title":"Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations","volume":"11","author":"Padhani","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejrad.2018.04.020_bib0145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A systematic review of the factors affecting accuracy of SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2018.04.020_bib0150","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00259-014-2714-x","article-title":"Tumor hypoxia and microscopic diffusion capacity in brain tumors: a comparison of (62)Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET\/CT and diffusion-weighted MR imaging","volume":"41","author":"Hino-Shishikura","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18301463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18301463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T22:47:50Z","timestamp":1530917270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X18301463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":30,"alternative-id":["S0720048X18301463"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.04.020","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-FDG PET\/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}